Nu Skin Posts Mixed Q4 2025 Results, Eyes Growth in India and Prism iO Rollout

Stonegate Capital Partners has updated its coverage on Nu Skin Enterprises Inc. (NYSE: NUS), revealing the company's fourth-quarter 2025 financial results that present a mixed picture of performance. The direct-selling beauty and wellness company reported revenue of $370.3 million, adjusted net income of $14.5 million, and adjusted earnings per share (EPS) of $0.29. These figures fell slightly short of Stonegate's estimates of $380.2 million, $15.1 million, and $0.30, respectively, placing revenue at the low end of guidance while EPS hit the high end. A key highlight was the performance of the Rhyz segment, which delivered $48.52 million in revenue, split between $42.45 million from Manufacturing and $6.07 million from Rhyz Other. Meanwhile, the core Nu Skin business demonstrated operational strength with a gross margin of 77.6% and disciplined cost management, as selling expenses declined to 40.8% of the core business. Management attributed the EPS performance to strategic market penetration, overall margin expansion, and a one-time tax benefit, emphasizing a continued focus on strategic initiatives despite the softer top-line results.

Looking ahead, Nu Skin's management outlined several critical strategic priorities that signal the company's future direction. The rollout of Prism iO is advancing and expected to progress through the first half of 2026, representing a significant technological or operational initiative. Furthermore, the company is actively pursuing growth in emerging markets, with a pre-launch underway in India and a full market opening anticipated in the second half of 2026. This geographic expansion into India and other emerging countries is positioned as a cornerstone for future revenue streams. For the full fiscal year 2026, management has provided EPS guidance with a midpoint of $1.00, offering investors a tangible benchmark for the year's profitability expectations. To view the full announcement, including downloadable images, bios, and more, interested parties can click here for comprehensive details directly from the source.

The announcement originates from Stonegate Capital Partners, a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Its affiliate, Stonegate Capital Markets, offers a full spectrum of investment banking services. The news was distributed via Reportable, Inc., and contacts for Stonegate are provided for further inquiry. This coverage update serves as a crucial resource for investors and market watchers tracking Nu Skin's financial health and strategic trajectory in the competitive beauty and wellness sector.